Cargando…
Safety assessment of drug combinations used in COVID-19 treatment: in silico toxicogenomic data-mining approach
Improvement of COVID-19 clinical condition was seen in studies where combination of antiretroviral drugs, lopinavir and ritonavir, as well as immunomodulant antimalaric, chloroquine/hydroxychloroquine together with the macrolide-type antibiotic, azithromycin, was used for patient's treatment. A...
| Autores principales: | , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Elsevier Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7483129/ https://www.ncbi.nlm.nih.gov/pubmed/32920000 http://dx.doi.org/10.1016/j.taap.2020.115237 |